Trending News

#Cancer Research UK #Gene mutation #Genetics / genomics #Oncology #Paediatrics #The Institute of Cancer Research

International team unlocks the genetic secrets of neuroblastoma

A team of international researchers have secured £1.5 ($1.9) million funding from Cancer Research UK (CRUK) to study the genetic secrets of childhood cancer neuroblastoma.  The project will be led by scientists at the University of Sheffield, alongside colleagues from The Institute of Cancer Research (ICR), Kings… Read More

#Cancer Research #News #Trending News

Pancreatic cancer
#Cancer drug targets #Gene mutation #Oncology #The Institute of Cancer Research

Algorithm identifies new potential targets for cancer drugs

Scientists have developed a tool which helps them better understand cancer’s survival tactics and could eventually lead to new treatments for dozens of cancers.  ‘Synthetic lethality’, the tactic of blocking pathways that cancer cells rely on, has so far mainly been successful in patients with BRCA-mutated breast,… Read More

#Cancer Research #News #Trending News

Robot for drug discovery
#Artificial intelligence (AI) #Automation / robotics #Drug discovery #Insilico Medicine #Lab automation #Lab technology

First bipedal humanoid AI scientist joins drug discovery lab

Insilico Medicine has deployed the first bipedal humanoid in its AI-powered fully-robotic drug discovery laboratory.   The humanoid, called ‘Supervisor’, will be used for data acquisition and data generation for training of the embodied AI systems to learn the skills of human laboratory scientists.   The work… Read More

#News #Trending News

Doctor points at child's brain scan
#Australia #Brain cancer #Checkpoint inhibitor therapies #Immunotherapy #Oncology #University of Sydney

Study shows potential for triple immunotherapy in glioblastoma

An experimental cancer treatment developed by researchers at the Melanoma Institute Australia paves the way for a clinical trial to be conducted by researchers at the Brain Cancer Centre in Melbourne.  It is the first documented use of neoadjuvant triple immunotherapy in glioblastoma, involving a combination of… Read More

#Cancer Research #News #Trending News

Gene sequence
#Drug discovery #High throughput screening #Lab technology #Next generation sequencing #Roche

Will Roche’s new SBX technology revolutionise sequencing?

Roche has unveiled its new breakthrough sequencing by expansion (SBX) technology, establishing a new category of next-generation sequencing.   According to the company, SBX chemistry, combined with an innovative sensor module, offers ultra-rapid, high-throughput sequencing that is both flexible and scalable for a broad range of applications. … Read More

#News #Trending News

Pregnant woman in hospital
#Muscle atrophy #Paediatrics #Prenatal

Successful first prenatal therapy for spinal muscular atrophy

A prenatal therapy for spinal muscular atrophy (SMA) with risdiplam has shown promise in a first-of-its-kind study.  Scientists at St Jude Children’s Research Hospital led the first in utero treatment of SMA with the orally administered drug risdiplam.   More than two years after the child… Read More

#News #Trending News

Monoclonal antibodies
#Inflammatory Bowel Disease #Monoclonal antibodies #Phase II trial #Sanofi #Teva

New data indicate duvakitug could “transform” IBD treatment

Sanofi and Teva Pharmaceuticals have revealed new results from their Phase IIb study of duvakitug for ulcerative colitis (UC) and Crohn’s disease (CD), the two most common forms of inflammatory bowel disease (IBD).   The results were shared in two oral presentations at the 20th Congress of the… Read More

#News #Trending News

AI clinical trials concept
#Antimicrobial resistance (AMR) #Artificial intelligence (AI) #Google #Imperial College London

AI co-scientist could supercharge science, say researchers

A complex problem that took scientists a decade to explain was solved in just two days by a new artificial intelligence (AI) tool, the BBC has reported.  Professor José Penadés and his team at from the Imperial College London Department of Infectious Disease had spent 10 years… Read More

#News #Trending News

Child having an eye test
#Gene therapy #Genetic diseases #MeiraGTx #Ophthalmology #UCL

Gene therapy treats rare genetic sight impairment in the UK

Four young children have gained improvements in their vision following treatment with a new genetic medicine through Moorfields Eye Hospital and UCL Institute of Ophthalmology, with the support of MeiraGTx.  The children were born with a severe impairment to their sight due to a rare genetic deficiency… Read More

#News #Trending News

bluebird bio
#Gene therapy #Genetic diseases #Mergers and acquisitions

bluebird bio agrees to acquisition due to “financial challenges”

bluebird bio has entered into a definitive agreement to be acquired by global investment firms Carlyle and SK Capital Partners in collaboration with a team of highly experienced biotech executives.  The decision was made after a third and final denial by the Food & Drug Administration (FDA) of bluebird’s appeal… Read More

#Business & Investment #News #Trending News

CRISPR Cas9
#Brain cancer #CRISPR #CRISPR screening #Oncology #The Institute of Cancer Research

CRISPR reveals new therapeutic target for glioblastoma

Scientists have shown for the first time that some of the most persistent cancer cells in glioblastoma rely on transforming growth factor beta-activated kinase 1 (TAK1) for survival and that inhibiting this enzyme leads to the death of the cells.  Furthermore, they have demonstrated that it is… Read More

#Cancer Research #News #Trending News

The extracellular matrix
#Barts Institute #Oncology #The Institute of Cancer Research #Tumour microenvironment (TME)

Cancer breakthrough could stop tumours before they metastasise

Scientists have discovered a new way to predict which tumours will become aggressive before they metastasise and spread around the body.  The research, published in Nature Communications, reveals how cancer cells are altered by their surroundings, enabling them to change their… Read More

#Cancer Research #News #Trending News

Neurons
#Lung cancer #Oncology #Small cell lung cancer #The Francis Crick Institute

Lung cancer cells build their own electrical network 

Researchers from the Francis Crick Institute have found that aggressive lung cancer cells can develop their own electric network, like that seen in the nervous system.  This unique property could make them less dependent on the environment surrounding the tumour and even spread more easily, say the… Read More

#Cancer Research #News #Trending News

Novartis head office
#Anthos Therapeutics #Cardiovascular disease #Mergers and acquisitions #Monoclonal antibodies #Novartis

Novartis acquires Anthos Therapeutics for $925 million

Novartis has agreed to acquire Anthos Therapeutics, a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathway.  Abelacimab is currently in Phase III development, with the lead indication for prevention of stroke and systemic embolism in patients with atrial fibrillation.  Novartis will make an… Read More

#Business & Investment #News #Trending News

National Institutes of Health
#Funding #National Institutes of Health (NIH) #Politics

NIH cuts billions in funding for medical research

The Trump administration in the US has announced plans to cut billions of dollars in funding for costs related to medical research funding in universities, hospitals and other scientific institutions.  These grants include payments for “indirect costs,” defined as “facilities” and “administration”, which cost up to $9… Read More

#News #Trending News